The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181: 1034-1042.
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Verbinnen, B.
Right arrow Articles by Ceuppens, J. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbinnen, B.
Right arrow Articles by Ceuppens, J. L.

Contribution of Regulatory T Cells and Effector T Cell Deletion in Tolerance Induction by Costimulation Blockadel

Bert Verbinnen*, An D. Billiau{dagger}, Jan Vermeiren*, Georgina Galicia*, Dominique M. A. Bullens*,{ddagger}, Louis Boon, Pascal Cadot*, Greet Hens*, Christiane Dewolf-Peeters§, Stefaan W. Van Gool*,{ddagger} and Jan L. Ceuppens2,*

* Division of Clinical Immunology, {dagger} Experimental Transplantation, {ddagger} Pediatrics, and § Morphology and Molecular Pathology, University Hospital, Catholic University of Leuven, Leuven, Belgium; and Bioceros, Utrecht, The Netherlands

Blocking of costimulatory signals for T cell activation leads to tolerance in several transplantation models, but the underlying mechanisms are incompletely understood. We analyzed the involvement of regulatory T cells (Treg) and deletion of alloreactive cells in the induction and maintenance of tolerance after costimulation blockade in a mouse model of graft-vs-host reaction. Injection of splenocytes from the C57BL/6 parent strain into a sublethally irradiated F1 offspring (C57BL/6 x C3H) induced a GVHR characterized by severe pancytopenia. Treatment with anti-CD40L mAb and CTLA4-Ig every 3 days during 3 wk after splenocyte injection prevented disease development and induced a long-lasting state of stable mixed chimerism (>120 days). In parallel, host-specific tolerance was achieved as demonstrated by lack of host-directed alloreactivity of donor-type T cells in vitro and in vivo. Chimerism and tolerance were also obtained after CD25+ cell-depleted splenocyte transfer, showing that CD25+ natural Treg are not essential for tolerance induction. We further show that costimulation blockade results in enhanced Treg cell activity at early time points (days 6–30) after splenocyte transfer. This was demonstrated by the presence of a high percentage of Foxp3+ cells among donor CD4+ cells in the spleen of treated animals, and our finding that isolated donor-type T cells at an early time point (day 30) after splenocyte transfer displayed suppressive capacity in vitro. At later time points (>30 days after splenocyte transfer), clonal deletion of host-reactive T cells was found to be a major mechanism responsible for tolerance.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a research grant from the Research Council of the Catholic University of Leuven (OT 06-67), by research grants from the Fund for Scientific Research-Flanders (G.0509.06 and G.0255.05) and by a grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders. B.V. is a recipient of a fellowship from Institute for the Promotion of Innovation through Science and Technology in Flanders. S.W.V.G. is a senior clinical investigator of the Fund for Scientific Research-Flanders. A.D.B. and D.M.A.B. are recipients of a postdoctoral fellowship from the Fund for Scientific Research.

2 Address correspondence and reprint requests to Dr. Jan Ceuppens, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. E-mail address: jan.ceuppens{at}uz.kuleuven.be

3 Abbreviations used in this paper: Treg, regulatory T cell; nTreg, natural Treg; GVHR, graft-vs-host reaction; GVHD, graft-vs-host disease; WBC, white blood cell.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.